Publication Name	World Journal of Hepatology
Manuscript ID	96914
Country	Spain

Received	2024-05-18 01:13
Peer-Review Started	2024-05-23 02:03
To Make the First Decision
Return for Revision	2024-06-18 06:27
Revised	2024-07-12 22:25
Second Decision	2024-07-17 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-17 07:59
Articles in Press	2024-07-17 07:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-22 01:55
Publish the Manuscript Online	2024-09-23 10:30

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medical Laboratory Technology
Manuscript Type	Editorial
Article Title	Kick-start for metabolomics in liver disease
Manuscript Source	Invited Manuscript
All Author List	Armando Guerra-Ruiz
ORCID	Author(s) ORCID Number Armando Guerra-Ruiz http://orcid.org/0000-0001-8896-8611
Funding Agency and Grant Number
Corresponding Author	Armando Guerra-Ruiz, PhD, Consultant Physician-Scientist, Laboratory Medicine, University Hospital Marques de Valdecilla, Avda Valdecilla s/n, Santander 39008, Cantabria, Spain. r-gruiz@hotmail.com
Key Words	Metabolomics; Liver disease; Biomarkers; Hepatology; Mass spectrometry; Hepatitis; Clinical biochemistry
Core Tip	This editorial explores the transformative potential of metabolomics in liver disease research and management. Highlighting four key studies, we explore how metabolomics aids in biomarker discovery, reveals altered biochemical pathways, supports personalized medicine, and elucidates disease mechanisms. By integrating metabolomics in clinical practice, we can enhance early diagnosis, optimize treatment strategies, and develop targeted therapies, ultimately improving patient outcomes. This comprehensive approach underscores the versatility and importance of metabolomics in advancing precision medicine for liver diseases.
Publish Date	2024-09-23 10:30
Citation	<p>Guerra-Ruiz A. Kick-start for metabolomics in liver disease. <i>World J Hepatol</i> 2024; 16(9): 1206-1210</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i9/1206.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i9.1206

Full Article (PDF)	WJH-16-1206-with-cover.pdf
Manuscript File	96914_Auto_Edited_015034.docx
Answering Reviewers	96914-answering-reviewers.pdf
Audio Core Tip	96914-audio.mp3
Conflict-of-Interest Disclosure Form	96914-conflict-of-interest-statement.pdf
Copyright License Agreement	96914-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	96914-non-native-speakers.pdf
Peer-review Report	96914-peer-reviews.pdf
Scientific Misconduct Check	96914-scientific-misconduct-check.png
Scientific Editor Work List	96914-scientific-editor-work-list.pdf
CrossCheck Report	96914-crosscheck-report.pdf